DR. STAVROS N. MOYSIDIS (M.D.) – Retina Specialist (Ophthalmology) Physician, NPI 1780023929
Retina Specialist (Ophthalmology) Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
2,665 OPHTHALMOLOGY in CA
Provider Addresses for DR. STAVROS N. MOYSIDIS (M.D.)
16500 VENTURA BLVD STE 250
ENCINO, CA 914362018
Phone: (818) 788-9333
Fax: (818) 788-9053
Type: Mailing
5400 BALBOA BLVD STE 126
ENCINO, CA 913165202
Phone: (818) 578-0004
Fax: (818) 578-0002
Type: Mailing
2031 W Alameda Ave Ste 300
Burbank, CA 915062960
Phone: (818) 762-0647
Fax: (818) 754-5349
Type: Location
2820 Townsgate Rd Ste 100
Westlake Village, CA 913613069
Phone: (805) 497-7976
Type: Location
1901 Solar Dr Ste 110
Oxnard, CA 930362642
Phone: (805) 497-7976
Type: Location
2031 W ALAMEDA AVE STE 300
BURBANK, CA 915062960
Phone: (818) 762-0647
Fax: (818) 754-5349
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 25 Open Payments records for all available years, with a total value of $809.
Total Amount is formed as General ($809) + Research ($0) + Ownership ($0) = $809.
Last reported payment date: 2024-12-10 • Largest payer in this snapshot: Apellis Pharmaceuticals, Inc. ($247).
Total Amount
$809
General + Research + Ownership
Payments
25
Total payment records
General Amount
$809
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-10
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Apellis Pharmaceuticals, Inc. | $247 |
| Genentech USA, Inc. | $139 |
| ABBVIE INC. | $94 |
| Alcon Vision LLC | $68 |
| Alimera Sciences, Inc. | $64 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2019-09-09
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20190909003210 | I | Ophthalmology | CA | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,901 | 19 | $0 |
| 92134 | Imaging of retina | 1,123 | 504 | $0 |
| 92014 | Established patient complete exam of visual system | 739 | 414 | $0 |
| 67028 | Injection of drug into eye | 415 | 113 | $0 |
| J7999 | Compounded drug, not otherwise classified | 359 | 80 | $0 |
Insurance plans in this area (ZIP 91436)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| O P H T H A L M O L O G Y | CA | |
| O P T O M E T R Y | CA | |
| O P H T H A L M O L O G Y | CA | |
| Ophthalmology, Plastic And Reconstructive Surgery | CA | |
| O P T O M E T R Y | CA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.